GLOW

GLOW is a research blend of GHK-Cu, BPC-157, and TB-500 that people run mainly for skin rejuvenation and wound healing; of the twenty medium-confidence community reports captured, the majority focus on cosmetic improvement and a smaller set on scar reduction, with nearly all positive. No consistent dose, timing, or cycling pattern is reported across the threads, so a settled protocol has not emerged. There is no FDA-approved indication for any component in this blend, meaning all human use is off-label or compounded.

GLOW

Research Evidence

Evidence shape

GLOW sits firmly in the animal-only tier; its single mapped indication rests entirely on preclinical mechanistic research, with zero registered human trials and no completed studies to evaluate. The full breadth of investigation is confined to that one non-human line, and no human studies are registered or completed. The absence is the signal: there are no terminated, withdrawn, or stalled human trials to parse, only a blank record where clinical evidence should be.

Depthhow much
0 registered trials
Breadthhow many areas
1 indication mapped
1 animal-only
Qualityhow rigorous
No completed trials
Breadth and depth2 rows captured
Human
direct clinical signal
0
Animal
translational support
1
In vitro
mechanistic support
1
HighMediumLow

Anecdotal efficacy

Price

1
USA/China
700 mg
$75.00
$0.11/mg
2
UK
70 mg
$21.54
$0.31/mg
3
--
70 mg
$24.99
$0.36/mg
4
US
70 mg
$40.00
$0.57/mg
5
US
70 mg
$39.99
$0.57/mg
6
US
700 mg
$499.99
$0.71/mg

price offers can be sorted by column

1-6 of 87

Dosing & Protocol

How GLOW is dosed across research, clinician, and community sources — each evidence tier kept separate so the dose range, frequency, timing, and cycling stay visible without flattening different levels of evidence.

Research trials
Published clinical-trial protocols
Typical dose
No quantified dose captured for this tier.

No structured protocol details captured for this tier yet.

Clinician practice
Doctor & published-protocol guidance
Typical dose
No quantified dose captured for this tier.

No structured protocol details captured for this tier yet.

Anecdotal
Community-reported real-world use · n = 16
Typical dose
No quantified dose captured for this tier.
Frequency
unspecified
Timing
unspecified
Route
subQ
Cycle
unspecified

Community reports for GLOW currently lack specific dose figures; however, anecdotal experiences frequently cite subcutaneous administration for skin rejuvenation and wound healing applications.

Peptide Deep Dive

Peptide Deep Dive is not projected for this peptide yet.

Peptide feedback

0 forum replies

Live community discussion for GLOW, shown here in the site layout and continued on the TVR forum.

Add feedback

No peptide feedback yet

Start the peptide feedback thread on the TVR forum.